piracetam has been researched along with thromboxane b2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alivanis, P; Grekas, D; Kalekou, H; Karamouzis, M; Papayianni, K; Tourkantonis, A | 1 |
| Alivanis, P; Grekas, D; Karamouzis, M; Pyrpasopoulos, M | 1 |
| Col-Debeys, C; Crasborn, L; Lavenne-Pardonge, E; Moriau, M; von Frenckell, R | 1 |
1 trial(s) available for piracetam and thromboxane b2
| Article | Year |
|---|---|
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.
Topics: Adult; Antithrombin III; Bleeding Time; Blood Coagulation; Blood Viscosity; Cell Membrane; Dose-Response Relationship, Drug; Double-Blind Method; Fibrinogen; Fibrinopeptide A; Humans; Male; Piracetam; Platelet Aggregation; Platelet Count; Platelet Factor 4; Reference Values; Thromboxane B2 | 1993 |
2 other study(ies) available for piracetam and thromboxane b2
| Article | Year |
|---|---|
Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Dogs; Drug Interactions; Kidney; Kidney Tubular Necrosis, Acute; Nifedipine; Piracetam; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Time Factors; Vasoconstriction | 1992 |
Piracetam as a potent inhibitor of plasma thromboxane B2 during hemodialysis.
Topics: Adult; Aged; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Piracetam; Pyrrolidinones; Renal Dialysis; Thromboxane B2 | 1989 |